145 related articles for article (PubMed ID: 21393158)
1. Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Tängdén T; Eriksson BM; Melhus A; Svennblad B; Cars O
J Antimicrob Chemother; 2011 May; 66(5):1161-7. PubMed ID: 21393158
[TBL] [Abstract][Full Text] [Related]
2. Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.
Kim JY; Sohn JW; Park DW; Yoon YK; Kim YM; Kim MJ
J Antimicrob Chemother; 2008 Aug; 62(2):416-21. PubMed ID: 18413317
[TBL] [Abstract][Full Text] [Related]
3. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
4. An outbreak of extended spectrum beta-lactamase producing Klebsiella pneumoniae in a neonatal intensive care unit.
Shenoy S; Hegde A; Dominic SR; Kamath S; Arvind N
Indian J Pathol Microbiol; 2007 Jul; 50(3):669-70. PubMed ID: 17883180
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection.
Quale JM; Landman D; Bradford PA; Visalli M; Ravishankar J; Flores C; Mayorga D; Vangala K; Adedeji A
Clin Infect Dis; 2002 Oct; 35(7):834-41. PubMed ID: 12228820
[TBL] [Abstract][Full Text] [Related]
6. Impact of cephalosporin restriction on incidence of infections with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an endemic setting.
Nadrah K; Pirs M; Kreft S; Mueller Premru M; Beovic B
J Chemother; 2018 May; 30(3):150-156. PubMed ID: 29431031
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.
Kritsotakis EI; Tsioutis C; Roumbelaki M; Christidou A; Gikas A
J Antimicrob Chemother; 2011 Jun; 66(6):1383-91. PubMed ID: 21454344
[TBL] [Abstract][Full Text] [Related]
8. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.
Cagnacci S; Gualco L; Roveta S; Mannelli S; Borgianni L; Docquier JD; Dodi F; Centanaro M; Debbia E; Marchese A; Rossolini GM
J Antimicrob Chemother; 2008 Feb; 61(2):296-300. PubMed ID: 18065411
[TBL] [Abstract][Full Text] [Related]
9. An outbreak of SHV-5 producing Klebsiella pneumoniae in a neonatal intensive care unit; meropenem failed to avoid fecal colonization.
Gundes S; Arisoy AE; Kolayli F; Karaali E; Turker G; Sanic A; Arisoy ES; Vahaboglu H
New Microbiol; 2005 Jul; 28(3):231-6. PubMed ID: 16240695
[TBL] [Abstract][Full Text] [Related]
10. Comment on: Control of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.
Huttner B; Pittet D; Harbarth S
J Antimicrob Chemother; 2008 Nov; 62(5):1165; author reply 1165-6. PubMed ID: 18658195
[No Abstract] [Full Text] [Related]
11. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
Samra Z; Ofir O; Lishtzinsky Y; Madar-Shapiro L; Bishara J
Int J Antimicrob Agents; 2007 Dec; 30(6):525-9. PubMed ID: 17931835
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic-resistant Klebsiella pneumoniae in Spain: analyses of 718 invasive isolates from 35 hospitals and report of one outbreak caused by an SHV-12-producing strain.
Oteo J; Garduño E; Bautista V; Cuevas O; Campos J;
J Antimicrob Chemother; 2008 Jan; 61(1):222-4. PubMed ID: 18024490
[No Abstract] [Full Text] [Related]
13. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase.
Peña C; Pujol M; Ardanuy C; Ricart A; Pallarés R; Liñares J; Ariza J; Gudiol F
J Hosp Infect; 2001 Jan; 47(1):53-9. PubMed ID: 11161899
[TBL] [Abstract][Full Text] [Related]
14. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.
Kontopoulou K; Protonotariou E; Vasilakos K; Kriti M; Koteli A; Antoniadou E; Sofianou D
J Hosp Infect; 2010 Sep; 76(1):70-3. PubMed ID: 20705205
[TBL] [Abstract][Full Text] [Related]
15. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility pattern and prevalence of extended spectrum beta-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi.
Grover SS; Sharma M; Pasha ST; Singh G; Lal S
J Commun Dis; 2004 Mar; 36(1):17-26. PubMed ID: 16295682
[TBL] [Abstract][Full Text] [Related]
17. Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit.
Song W; Lee KM; Kim HS; Kim JS; Kim J; Jeong SH; Roh KH
Int J Antimicrob Agents; 2006 Dec; 28(6):520-4. PubMed ID: 17095195
[TBL] [Abstract][Full Text] [Related]
18. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
Panhotra BR; Saxena AK; Al-Ghamdi AM
Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
[TBL] [Abstract][Full Text] [Related]
19. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
[TBL] [Abstract][Full Text] [Related]
20. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
